NCT01556074

Brief Summary

The primary objective of this preliminary study is to estimate sleep outcome effect sizes and determine feasibility for a novel yoga treatment of insomnia in participants with post traumatic stress disorder (PTSD). Additional objectives are to evaluate relationships of sleep outcomes with measures of other PTSD symptoms, psychosocial health and possible mechanisms of action.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2012

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 8, 2012

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 16, 2012

Completed
3 months until next milestone

Study Start

First participant enrolled

June 1, 2012

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2014

Completed
Last Updated

August 4, 2014

Status Verified

August 1, 2014

Enrollment Period

1.7 years

First QC Date

March 8, 2012

Last Update Submit

August 1, 2014

Conditions

Keywords

Post traumatic stress disorderPTSDInsomniaSleepYogaMeditationMental HealthSleep QualityActigraphySleep DiariesAutonomicSocial HealthInteroceptionAttention RegulationEmotion Regulation

Outcome Measures

Primary Outcomes (1)

  • Change in sleep quality measured by wrist actigraphy and daily sleep diaries

    Averages of: 2-week pre-treatment baseline; last 2 weeks of treatment; 2-week long-term follow-up occuring 3-months post-treatment

Secondary Outcomes (11)

  • Acceptability of yoga program as measured by a 2-item Yoga Evaluation Form (End) and a 2-item Yoga Evaluation Form (Followup)

    One occurrence at 1 week following intervention, one occurrence at 3 months post-intervention

  • Treatment adherence as measured by attendance to group yoga classes and play count monitoring of mp3's for home practice on non-class days

    Averages over duration of intervention (8 weeks total)

  • Accrual rate calculated from recruitment and consent information

    Monthly for duration of recruitment period (expected to be 3 months per cohort, up to 6 to 9 months for 2 to 3 cohorts total)

  • Attrition rate calculated from disempanelment information

    Monthly for duration of data collection and treatment (approximately 6 months per cohort, up to 18 months for 2 to 3 cohorts total)

  • Change in PTSD symptoms as measured by the 17-item, self-reported PTSD Checklist-- Civilian version (PCL-C)

    Once at 1-week before intervention, once at 1 week post-intervention, once at 3 months post-intervention

  • +6 more secondary outcomes

Study Arms (1)

Yoga treatment

EXPERIMENTAL
Behavioral: Yoga treatment

Interventions

Yoga treatmentBEHAVIORAL

Biweekly 90-minute group yoga classes for 8 weeks and on non-class days participants will be asked to devote 15 minutes per day to a prescribed home yoga practice.

Yoga treatment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male and non-pregnant female adults at least 18 years of age.
  • A DSM-IV-TR diagnosis of post-traumatic stress disorder (PTSD).
  • Naïve to yoga and other meditative practices, defined as less than one hour per week for the past 6 months.
  • Potential subjects receiving ongoing medical or psychological treatment are eligible, as long as treatment remains stable over the course of the study and does not include more than one hour weekly of mind-body medicine (strategies directly related to meditation and yoga).
  • No more than 2 alcoholic or caffeinated drinks/day
  • No illicit drug use
  • Potential subjects are eligible if they have been on stable dosage (not PRN) of medication for PTSD symptoms including sleep disturbances and any medication that may influence sleep for at least 6 weeks prior to the study, and be willing to continue with same dosage for the duration of the study.
  • No current substance abuse, defined as diagnosis of substance abuse or dependence disorder within the past year, and/or in/outpatient treatment for substance abuse or dependence in the past 6 weeks.
  • No transcontinental travel over the course of the study.
  • No night-shift or rotating shift work over the course of the study.
  • Insomnia based on the American Academy of Sleep Medicine's Research Diagnostic Criteria (RDC) for insomnia due to a mental health disorder
  • Potential subjects are eligible to participate in this study if they have sufficient mental and physical ability to fully participate in the parameters of the study. Subjects must be able to understand and comply with instructions in the group yoga sessions and home practice, complete questionnaires, participate in clinical interviews, and take part in all data collection activities. Subjects with severe mental or physical concerns that may prevent them from understanding and/or complying with the treatment will be excluded. For example, potential subjects confined to wheelchairs will not be eligible, although subjects with artificial limbs who are able to reasonably participate in the intervention may be deemed eligible. These determinations will be made during discussions with potential subjects on a case by case basis during the screening process.

You may not qualify if:

  • \- Potential subjects are ineligible if pregnant.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Brigham and Women's Hospital

Boston, Massachusetts, 02116, United States

Location

MeSH Terms

Conditions

Stress Disorders, Post-TraumaticSleep Initiation and Maintenance DisordersPsychological Well-BeingEmotional Regulation

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental DisordersSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesPersonal SatisfactionBehaviorSelf-ControlSocial Behavior

Study Officials

  • Jessica J Noggle Taylor, PhD

    Emory University

    PRINCIPAL INVESTIGATOR
  • Sat Bir S Khalsa, PhD

    Brigham and Women's Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor in Medicine

Study Record Dates

First Submitted

March 8, 2012

First Posted

March 16, 2012

Study Start

June 1, 2012

Primary Completion

February 1, 2014

Study Completion

February 1, 2014

Last Updated

August 4, 2014

Record last verified: 2014-08

Locations